IDEXX Laboratories, Inc. Overview
Pro stress-test →IDEXX Laboratories is a global leader in veterinary diagnostics, software, and water microbiology testing, listed on NASDAQ since 1991 as an S&P 500 member. The company develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock, including point-of-care test kits, chemistry and hematology analyzers, reference lab services, and veterinary practice management software.
Strategic Profile
Pro stress-test →IDEXX achieved pivotal 2025 milestones with successful launches of IDEXX Cancer Dx for canine lymphoma and meaningful adoption of IDEXX inVue Dx, expanding the role of diagnostics in earlier disease detection. The company derives approximately 35% of revenue from outside the United States, demonstrating strong global diversification. IDEXX maintains highly profitable operations with a 61.7% gross margin and 65% return on equity over the past 12 months.
Competitive Landscape
Pro stress-test →IDEXX competes against companies including Revvity, BIONOTE, Randox, Great Basin Scientific, and Luminex in veterinary diagnostics. The company maintains market leadership through integrated software platforms, broad diagnostic panel offerings, and strong vet relationships. The rapidly growing pet healthcare market with increasing pet ownership and spending presents ongoing opportunities for IDEXX's diagnostic products, practice management solutions, and pet health services.
Industry Context
IDEXX Laboratories, Inc. operates in Veterinary Diagnostics, Medical Devices & Software, Water Testing.
Key facts
Founded: 1983 · Headquarters: Westbrook, Maine, US · Employees: 11,000 · Revenue: $4.3B · Market cap: $50.2B